Preventable Risk Factors Associated with BPPV Dizziness Occurrence and Recurrence

Benign Paroxysmal Positional Vertigo (BPPV) is a common cause of vertigo, and while repositioning maneuvers like the Epley are highly effective for treatment, new research is shedding light on ways to prevent BPPV from recurring. Metabolic health, hormones, and bone strength all play important roles.

---

Vitamin D and Calcium Metabolism

Vitamin D deficiency is strongly linked to recurrent BPPV. Since vitamin D regulates calcium metabolism and bone health, low levels may weaken the inner ear’s calcium carbonate crystals (otoconia), making them more likely to dislodge.

👉 Evidence shows that supplementing vitamin D in deficient patients reduces recurrence rates and even improves balance and muscle strength in older adults.

---

Estrogen and Hormonal Balance

Estrogen supports bone and otoconia health. In postmenopausal women, reduced estrogen levels may contribute to higher rates of BPPV.

• Hormone Replacement Therapy (HRT): Some studies suggest estrogen therapy may lower recurrence risk, though treatment must be personalized due to potential side effects.

• Other hormones: Thyroid and glucocorticoids also influence otoconia metabolism, reinforcing the role of overall endocrine health.

  
  

---

Bisphosphonates and Bone Strength

Bisphosphonates—commonly prescribed for osteoporosis—may indirectly prevent BPPV recurrence. By improving bone density and stabilizing calcium metabolism, these drugs could help protect the otoconia in the inner ear.

👉 For patients with osteoporosis and recurrent BPPV, bisphosphonate therapy may provide a dual benefit: strengthening bones and reducing vertigo episodes.

---

Stay Active and Avoid Prolonged Bed Rest

A sedentary lifestyle or long periods of lying down (such as after surgery or illness) can increase the risk of BPPV. Regular movement and postural changes may help prevent otoconia from settling in the semicircular canals.

Even simple activities—walking, stretching, or gentle neck mobility—can have a protective effect.

---

Prevention at a Glance

Factor	Preventive Strategy
Vitamin D	Correct deficiencies through supplements or safe sunlight exposure
Estrogen	Consider HRT in postmenopausal women (individualized medical decision)
Bisphosphonates	May help in patients with osteoporosis and recurrent BPPV
Physical Activity	Stay active; avoid prolonged immobility or strict bed rest
General Health	Monitor thyroid, bone, and hormonal health regularly

---

Final Thoughts

Prevention of BPPV is moving beyond head maneuvers to a more comprehensive, whole-body approach:

• Maintain vitamin D levels

• Support hormonal balance, especially in postmenopausal women

• Use bisphosphonates when indicated for osteoporosis

• Keep active and avoid prolonged immobility

By addressing these factors, patients may be able to reduce how often BPPV returns and improve overall quality of life.

---

1. Guerra, M. A., & Devesa, J. (2020). Causes and treatment of idiopathic benign paroxysmal positional vertigo based on endocrinological and other metabolic factors. Journal of Otology, 15(3), 95–100.

2. Jeong, S. H., Kim, J. S., Shin, J. W., et al. (2013). Decreased serum vitamin D in idiopathic benign paroxysmal positional vertigo. Journal of Neurology, 260(3), 832–838.

3. Talaat, H. S., Kabel, A. M., Khaliel, L. H., et al. (2015). Reduction of recurrence rate of benign paroxysmal positional vertigo by treatment of vitamin D deficiency. European Archives of Oto-Rhino-Laryngology, 272(9), 2249–2253.

4. Toshiaki Yamanaka 1, Shiho Shirota, Yachiyo Sawai, Takayuki Murai, Nobuya Fujita, Hiroshi Hosoi. (2013). Osteoporosis as a risk factor for the recurrence of benign paroxysmal positional vertigo. Laryngoscope, 123(11):2813-6.

5. Joaquín Guerra, Jesús Devesa (2020). Causes and treatment of idiopathic benign paroxysmal positional vertigo based on endocrinological and other metabolic factors. Journal of Otology, 15(4): 155-160.